ImmunoTherapy Bridge 2023

 

ImmunoTherapy Bridge 2023
A

IO in Metastatic Non-Oncogene Addicted NSCLC: Consolidated Options to Cover the Unmet Need

By ImmunoTherapy Bridge 2023 FEATURING Alessandro Morabito
By ImmunoTherapy Bridge 2023 FEATURING Alessandro Morabito
80 views
January 9, 2024
0 Comments
Login to view comments. Click here to Login
Videos
15:37
ImmunoTherapy Bridge 2023

What’s New in NSCLC & Mesothelioma Immunotherapy

Feat. A. Morabito
16:18
ImmunoTherapy Bridge 2023

Innovating Immunotherapy for Pancreatic Cancer

Feat. G. Lesinski
16:54
ImmunoTherapy Bridge 2023

Immunoscore vs. Gene Signature - PRO Immunoscore

Feat. J. Galon
15:09
ImmunoTherapy Bridge 2023

Best of SITC 2023 for Clinical Development and IO Trials

Feat. P. A. Ascierto
20:06
ImmunoTherapy Bridge 2023

Bispecific vs. Combination Therapy - PRO Combination Therapy

Feat. A. Patnaik
11:26
ImmunoTherapy Bridge 2023

Bispecific vs. Combination Therapy - PRO Bispecific

Feat. J. Gulley
14:18
ImmunoTherapy Bridge 2023

Neo-Antigens vs. Alternative Antigens - PRO Neo-Antigens

Feat. S. Schoenberger
12:21
ImmunoTherapy Bridge 2023

Immunotherapy for HCC: Current Status & Future Perspectives

Feat. P. Federico
17:45
ImmunoTherapy Bridge 2023

Activating Innate Immunity in Prostate Cancer: From Bedside-to-Bench…

Feat. A. Patnaik
13:30
ImmunoTherapy Bridge 2023

Surviving in the Lymphoma Microenvironment: A Tough Challenge for CA…

Feat. M. Ruella
16:02
ImmunoTherapy Bridge 2023

Novel Insights Into the Mechanisms of Radiation-Induced Anti-Tumor I…

Feat. S. Demaria
17:25
ImmunoTherapy Bridge 2023

New Developments in Immunotherapy for Ovarian Cancer

Feat. A. Odunsi
18:55
ImmunoTherapy Bridge 2023

Immunotherapy in GI Cancer: Current Treatment Landscape and Challeng…

Feat. A. Avallone
13:53
ImmunoTherapy Bridge 2023

IO Combinations in aRCC: New Achievements and Challenges

Feat. R. Iacovelli
15:39
ImmunoTherapy Bridge 2023

Neoadjuvant IO: Non-Melanoma Skin Cancer

Feat. N. Gross
15:03
ImmunoTherapy Bridge 2023

Spatial Omics in Immunotherapy Trials: Unpacking the Challenges

Feat. C. Bifulco
15:54
ImmunoTherapy Bridge 2023

Non-Melanoma Skin Cancers

Feat. P. A. Ascierto
15:22
ImmunoTherapy Bridge 2023

Engage, Expand, Enable: Combination IO Strategy for Cold Tumors

Feat. J. Gulley
13:20
ImmunoTherapy Bridge 2023

IO in Metastatic Non-Oncogene Addicted NSCLC: Consolidated Options t…

Feat. A. Morabito
14:18
ImmunoTherapy Bridge 2023

How Immunotherapy Changed the Treatment Story for Endometrial and Ce…

Feat. M. Bartoletti
15:40
ImmunoTherapy Bridge 2023

Updates on Radiation and Immunotherapy

Feat. S. Formenti